NCT02028533View on ClinicalTrials.gov

Cocaine Opioid Oxytocin Option - Limited

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Opioid Use DisorderCocaine Use Disorder
Interventions
DRUG

Oxytocin

DRUG

Placebo

Trial Locations (1)

94110

San Francisco General Hospital Opiate Treatment Outpatient Program, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02028533 - Cocaine Opioid Oxytocin Option - Limited | Biotech Hunter | Biotech Hunter